Form 8-K PFIZER INC For: Jun 18
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Pfizer reaffirms 2026 guidance after CFO transition news
June 18, 2026 1:18 PM EDTPfizer (NYSE: PFE) reaffirmed its full-year 2026 financial guidance following the announcement of a Chief Financial Officer transition on June 18, 2026.
The company maintained its forecast for revenues in a range of $59.5 billion to $62.5 billion, and adjusted diluted earnings per share in a range of $2.80 to... More
